Pairing next generation software, analytic, and generative AI with next generation
Regenerative Medicine is using the body's engineered and modified cells to repair, replace,
regenerate, and rejuvenate tissues and organs. The areas of most active research are cell and
gene therapy and stem cells.
Tissue Engineering & BioMaterials
Direct T-cell re-programming
Cellular Scaffolds and Matrices
Ongoing Global Clinical Trials in Cell and Gene Therapy
Fewer than 50% of clinical supply leaders have confidence in
their ability to supply cell and gene therapy trials.
Login or Register to learn more.
We deliver decades of academic promise to clinical reality, just-in-time.
Drug development, iterative formulations, manufacturing, and clinical trials are inextricably
linked, with patient inclusion at every step.
MDVerse is the crucial integration of the drug creator,
CDMO, academia, clinical site, and materials ecosystem.
@dawndaniel - MD
MDVerse enables the revolution in advanced therapies by
leveraging our next-generation software, analytics, and AI/ML with industry best practices
to ensure precision therapeutics are delivered within the entire ATMP ecosystem
MD, FAASM, Co-Founder, CEO
MD, MSc, DSc, Board Member/Consultant
Consultant, ATMP Domain Expert
Send us a message
Please describe your interest in MDVerse